Myosin Therapeutics' MT-125 granted US FDA Fast Track designation in glioblastoma

Boehringer Ingelheim's JASCAYD (nerandomilast) IPF treatment gains Chinese regulatory approval

Eterna Health and Dr Adeel Khan Pioneer First Regenerative Treatment Using Small Pluripotent Stem Cells (SPSCs)

ACM Biolabs reports ACM-CpG Phase 1 study findings in tumour treatment

Galera Therapeutics sells dismutase mimetics portfolio to Biossil in USD108.5m agreement

Kyowa Kirin reports new registry data showing overall survival benefit with mogamulizumab in advanced CTCL

Arcturus reports interim Phase 2 data for ARCT-032 in cystic fibrosis

Sanofi's efdoralprin alfa shows superior results in phase 2 study for AATD

PureTech highlights Phase 2b data supporting deupirfenidone's safety and efficacy in older IPF patients

Genflow Biosciences publishes second European patent application for SIRT6 Variant in NASH

Trellus Health signs contract with leading global CRO and expands clinical trial offerings

GSK reports positive Phase III data for low-carbon version of Ventolin inhaler

Terns Pharmaceuticals reports topline 12-week data from Phase 2 trial of TERN-601 in obesity

The Los Angeles Trust for Children's Health Appoints Dr Sarah Rodman as New Executive Director

Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio